ALC · Alcon Inc.
$70.17
-0.65% last session
End-of-day data · close of 2026-10-23
Market cap
$34B
Enterprise value
$38B
Trailing P/E
53.2
Forward P/E
17.7
Dividend yield
1.0%
Beta
0.73
Avg volume
2M
Employees
25K
Daily Change %
-0.65%
5 Days Change
6.72%
10 Days Change
12.11%
30 Days Change
8.01%
60 Days Change
-4.17%
Month to Day Change
10.46%
Year to Day Change
-9.94%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ALC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-21
Latest call per bank · past 12 months
Barclays
Equal-Weight$70.00
-0.2% vs priceJefferies
Buy$85.00
+21.1% vs priceJP Morgan
Neutral$78.40
+11.7% vs priceWells Fargo
Overweight$86.00
+22.6% vs priceBank of America
Underperform$75.00
+6.9% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-21 | Needham | Reiterates | Buy | $98.00 |
| 2026-10-12 | BTIG | Maintains | Buy | $82.00 → $74.00 |
| 2026-10-07 | Barclays | Initiates | Equal-Weight | $0.00 → $70.00 |
| 2026-09-22 | Jefferies | Maintains | Buy | $95.00 → $85.00 |
| 2026-09-15 | Needham | Reiterates | Buy | $98.00 |
| 2026-08-12 | JP Morgan | Maintains | Neutral | $77.53 → $78.40 |
| 2026-08-12 | Mizuho | Maintains | Outperform | $80.00 → $85.00 |
| 2026-08-11 | Needham | Maintains | Buy | $95.00 → $98.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 65 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 3.2% above the 50-day MA ($67.96).
- bearish: Price vs 200-day MA: Trading 2.6% below the 200-day MA ($72.04).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.90) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($62.02) and high ($86.76).
ALC Price Chart
Loading chart for ALC…
Fundamentals
About Alcon Inc.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$160B -21.6% YTD
BDX
Becton, Dickinson and Company
$54B 33.9% YTD
MDLN
Medline Inc.
$46B -17.0% YTD
RMD
ResMed Inc.
$36B 5.9% YTD
WST
West Pharmaceutical Services, I
$28B 43.5% YTD
SOLV
Solventum Corporation
$15B 10.4% YTD
BAX
Baxter International Inc.
$13B 34.4% YTD
AVTR
Avantor, Inc.
$12B 49.6% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.